文献速递冠心病外科瓣膜外科

静脉氨基酸治疗对心脏手术患者肾脏保护作用的初步随机对照试验

Intravenous amino acid therapy for kidney protection in cardiac surgery patients: A pilot randomized controlled trial.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-12-15

该初步随机对照试验纳入69例体外循环心脏手术成人患者,比较标准治疗与麻醉诱导后立即持续静脉输注标准氨基酸对肾功能的影响。结果显示氨基酸组急性肾损伤持续时间显著缩短、估算肾小球滤过率提高、每日尿量增加,但肾功能障碍持续时间无差异。结论需多中心试验验证。

要点

  • 麻醉诱导后立即输注标准氨基酸可缩短体外循环心脏手术后急性肾损伤持续时间。

核心结论

  • 麻醉诱导后立即开始输注标准氨基酸未改变肾功能障碍持续时间,但急性肾损伤持续时间、估算肾小球滤过率和尿量等关键肾功能指标显著改善。

研究设计与样本

  • 初步随机对照试验,纳入69例拟接受体外循环时间超过1小时的心脏手术成人患者,随机分为标准治疗组(n=36)和氨基酸输注组(n=33)。
  • 患者平均年龄71.5岁(标准差9.2),女性19/69例;手术类型包括冠状动脉旁路移植术(37/69)、瓣膜手术(24/69)、冠状动脉旁路移植联合瓣膜手术(6/69)及其他手术(2/69)。
  • 平均体外循环时间268分钟(标准差136)。

临床怎么用

  • 对于体外循环心脏手术患者,可考虑在麻醉诱导后立即开始持续静脉输注标准氨基酸以改善急性肾损伤持续时间、估算肾小球滤过率和尿量。
  • 该干预对肾功能障碍持续时间无显著影响,临床决策需结合其他肾功能指标综合评估。

局限性

  • 本研究为初步单中心随机对照试验,样本量较小(69例),结果需多中心临床试验重复验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether a continuous intravenous infusion of standard amino acids could preserve kidney function after on-pump cardiac surgery. METHODS: Adult patients scheduled to receive cardiac surgery lasting longer than 1 hour on-pump were randomized to standard care (n = 36) or an infusion of amino acids initiated immediately after induction of anesthesia (n = 33). The study's primary outcome measurements assessed renal function. These assessments included duration of renal dysfunction, duration and severity of acute kidney injury (AKI), estimated glomerular filtration rate (eGFR) over time, urine output, and use of renal-replacement therapy. Complications and other measures of morbidity were also assessed. RESULTS: Sixty-nine patients (mean age 71.5 [standard deviation 9.2] years; 19 of 69 women) were enrolled and randomized. Patients received coronary artery bypass graft surgery (37/69), valve surgery (24/69), coronary artery bypass graft and valve surgery (6/69), or other procedures (2/69). Mean on-pump time was 268 [standard deviation 136] minutes. Duration of renal dysfunction did not differ between the groups (relative risk, 0.86; 95% confidence interval [CI], 0.19-3.79, P = .84). However, patients who received the amino acid infusion had a reduced duration of AKI (relative risk, 0.02; 95% CI, 0.005-0.11, P < .0001) and greater eGFR (+10.8%; 95% CI, 1.0%-20.8%, P = .033). Daily mean urine output was also significantly greater in patients who received the amino acid infusion (1.4 ± 0.5 vs 1.7 ± 0.9 L/d; P = .046). CONCLUSIONS: Commencing an infusion of standard amino acids immediately after the induction of anesthesia did not alter duration of renal dysfunction; however, other key measures of renal function (duration of AKI, eGFR and urine output) were significantly improved. These results warrant replication in multicenter clinical trials.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Pu H, Doig GS, Heighes PT, et al. Intravenous amino acid therapy for kidney protection in cardiac surgery patients: A pilot randomized controlled trial. J Thorac Cardiovasc Surg. 2018. PMID: 30685166. doi:10.1016/j.jtcvs.2018.11.097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。